Studies using Rab3D knockdown or overexpression in breast cancer cells strongly suggest that this Rab-GTPase regulates EMT via the activation of the Akt/GSK-3β/Snail pathway (Yang et al. 2015). This evidence concerns the gene RAB3D and breast carcinoma.